MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED
Clinical trials for MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to boost transplant success in rare blood cancer
Disease control Recruiting nowThis study tests whether giving a chemotherapy drug (decitabine) plus a targeted therapy (ruxolitinib, fedratinib, or pacritinib) before a stem cell transplant helps people with advanced myeloproliferative neoplasms (MPN) get to transplant and have better outcomes. About 25 adult…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Moving with purpose: new study tests diet and exercise for MPN patients
Symptom relief Recruiting nowThis pilot study tests whether a 12-week nutrition and exercise program is feasible for patients with myeloproliferative neoplasms (MPNs), a group of blood cancers. Thirty participants will take virtual and in-person classes to learn healthier eating and physical activity habits.…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Massive new study aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis long-term observational study is enrolling 5,000 adults with myeloproliferative neoplasms (MPNs)—rare blood cancers like polycythemia vera and myelofibrosis. Researchers will collect health records, patient surveys, and insurance data over at least five years to track sympto…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM, NOT OTHERWISE SPECIFIED
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC